CenterWatch Acquired by Founder Ken Getz
Ken Getz, the founder of CenterWatch—a clinical trials information services company—along with private equity investors has purchased the company from Jobson Medical Information. The acquisition was completed in April.
Getz founded CenterWatch in 1994 and established the company as a provider of operating and business information on the $40 billion global clinical trials industry. Getz sold the company to the Thomson Corporation in 1998. CenterWatch was subsequently sold to Jobson Medical Information in 2007.
“I am very excited to have CenterWatch back,” said Getz. “We have plans to modify and improve our print- and web-based publications and services while adding new offerings to assist investigative sites, pharmaceutical and biotechnology companies, contract research organizations and other service providers in being better informed, more effective and successful.”
The May issue of The CenterWatch Monthly newsletter features results and analysis of the 2010 Survey of Investigative Sites in Europe.
Getz is the Chairman of CISCRP—a nonprofit organization that he founded to educate and raise public awareness of the clinical research enterprise—and a Senior Research Fellow at the Tufts Center for the Study of Drug Development where he studies R&D management and operating models, investigative site, outsourcing, and study volunteer trends and policies.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
